Management of Multifocal-Multicentric Breast Cancer: Current Perspective

Chirurgia (Bucur). 2017 Jan-Feb;112(1):12-17. doi: 10.21614/chirurgia.112.1.12.


The incidence of multifocal (MF) and multicentric (MC) breast cancer has a wide variation among different clinical studies, mostly due to the lack of a standardized classification and definition of these two separate entities. The optimal surgical treatment for multiple ipsilateral breast cancer remains a long debated subject. Multifocal and multicentric breast cancer is usually considered a relative contraindication for breast conserving therapy (BCT). In this narrative review we analyzed differences between MC and MF early breast cancer, the role of magnetic resonance imaging (MRI) in detection of multiple breast lesions, and its role in the surgical approach. We evaluate data from the literature about feasibility of breast conservative surgery and loco-regional treatment modalities. Recent studies brought evidence that treatment of patients with MC/MF breast cancer with BCT plus radiotherapy and adjuvant systemic therapy can have low-rates for in-breast recurrence. Prospective studies are needed to confirm these findings.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy*
  • Chemotherapy, Adjuvant* / methods
  • Evidence-Based Medicine
  • Female
  • Humans
  • Magnetic Resonance Imaging* / methods
  • Mastectomy* / methods
  • Mastectomy, Segmental
  • Neoplasm Staging
  • Radiotherapy, Adjuvant / methods
  • Treatment Outcome